GenScript Bio (01548): CARVYKTI's fourth quarter trade sales revenue is approximately 334 million US dollars.
Kingsley Biotechnology (01548) released an announcement regarding the collaboration between Legend Biotech and Janssen Biotech...
GENSCRIPT BIO (01548) announced that, based on the cooperation and licensing agreement entered into by Legend Biotech and Janssen Biotech, Inc. (Johnson & Johnson) on December 21, 2017, CARVYKTI is expected to generate approximately $334 million in trade sales revenue by the end of the quarter ending December 31, 2024.
Related Articles
Merck & Co., Inc. (MRK.US), Bristol-Myers Squibb (BMY.US) and several other pharmaceutical companies have agreed to lower drug prices in the United States in exchange for tariff exemptions and policy support from the Trump administration.
NVIDIA Corporation (NVDA.US) relative to the semiconductor index is at a ten-year low in valuation! Bernstein says that buying at this time will yield an average return rate of over 150%.
.png)
With Tesla, Inc. (TSLA.US) CEO Musk having a close relationship, it is rumored that Morgan Stanley may lead SpaceX's epic IPO.
Merck & Co., Inc. (MRK.US), Bristol-Myers Squibb (BMY.US) and several other pharmaceutical companies have agreed to lower drug prices in the United States in exchange for tariff exemptions and policy support from the Trump administration.
NVIDIA Corporation (NVDA.US) relative to the semiconductor index is at a ten-year low in valuation! Bernstein says that buying at this time will yield an average return rate of over 150%.
With Tesla, Inc. (TSLA.US) CEO Musk having a close relationship, it is rumored that Morgan Stanley may lead SpaceX's epic IPO.
